Zynex Shares Trade Higher After Reporting a 95% Increase in Q3 Orders
Source: Streetwise Reports  (10/2/19)
Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. More >

U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer
Source: Streetwise Reports  (9/30/19)
The system, target markets and the marketing campaign for it are discussed in a Dawson James Securities report. More >

Medtronic Stock Hits All-Time High After Raising 2020 EPS Outlook
Source: Streetwise Reports  (8/20/19)
Dublin-based Medtronic reported Q1/20 earnings and revised its full-year earnings outlook upward sending shares up more than 5% today. More >

InMode Reports Solid Q2 Earnings and Appoints Paula Abdul as Brand Ambassador
Source: Streetwise Reports  (8/14/19)
InMode Ltd. reported Q2/19 earnings and announced that international pop superstar Paula Abdul will be its brand ambassador sending shares "Straight Up" 15% as investors "Rush Rush" to purchase shares today. More >

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control'
Source: Streetwise Reports  (8/2/19)
The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. More >

Align Technology Reports Strong Q2 Growth but China Sales Worries Leave Investors Frowning
Source: Streetwise Reports  (7/25/19)
Orthodontic and GP Dental medical device maker Align Technology announced a 24.6% increase in sales volume of its Invisalign products in its Q2/19 earnings report, but investors are not smiling much over China growth concerns as the shares of the company have fallen more than 25%. More >

Edwards Lifesciences Gets a Charge on Positive Q2 Earnings Report
Source: Streetwise Reports  (7/24/19)
Edwards Lifesciences is trading higher after reporting higher than expected adjusted earnings for Q2/19. The company estimates that the FDA will approve its SAPIEN 3 valve and SAPIEN 3 Ultra system in Q3/19. More >

Biotech Demonstrates Superiority of Polyp-Detecting Product
Source: Streetwise Reports  (7/17/19)
The study results and their meaning are reviewed in an H.C. Wainwright & Co. report. More >

Biotech Incorporates Urologists' Feedback Into Device Design
Source: Streetwise Reports  (7/17/19)
This step moves the product further down the development track. More >

Health Technology Company Recuperating Well
Source: Clive Maund for Streetwise Reports  (7/3/19)
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play. More >

Biotech Receives FDA Approval of Second-Generation Medical Device
Source: Streetwise Reports  (6/12/19)
The product's improvements and the company's commercialization approach were summarized in a Ladenburg Thalmann report. More >

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming
Source: Streetwise Reports  (5/15/19)
A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. More >

Augmented Reality Firm Moves into Medical Devices Arena
Source: Streetwise Reports  (4/9/19)
This technology company continues to diversify the end markets for its e-commerce platform. More >

Firm Launches App to Help Physicians Provide Virtual Counseling
Source: Streetwise Reports  (3/5/19)
This new initiative combines emerging technologies and human skill-based expertise. More >

Medical Device Firm Develops Nitric Oxide Delivery Unit for Clinic Use
Source: Streetwise Reports  (2/6/19)
This new machine takes the company's product line count to four. More >

Health Stock 'Looking Set to Bounce Back After 90% Drop'
Source: Clive Maund for Streetwise Reports  (12/11/18)
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. More >

Neuromonitoring Stock 'Ready to Rally'
Source: Clive Maund for Streetwise Reports  (11/26/18)
Technical analyst Clive Maund charts a neuromonitoring company that he believes is undervalued. More >

Biotech Files Patent Application for Nitric Oxide Delivery Device
Source: Streetwise Reports  (11/16/18)
With this development, the company advances blood/plasma transfusion technology.
More >

Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements
Source: Streetwise Reports  (10/9/18)
This Utah-based company rolled out an online campaign that highlights its strategic repositioning. More >

Company with Cancer Radiotherapy Grows Revenue for Six Consecutive Quarters
Source: Streetwise Reports  (10/3/18)
An H.C. Wainwright & Co. report reviewed this company's Q4/18 earnings and opportunities for increasing it. More >

Surgical Robotics Developer Demonstrates Technology at Medical Conference
Source: Streetwise Reports  (10/3/18)
A Ladenburg Thalmann report relayed how this Massachusetts company participated at the Transcatheter Cardiovascular Therapeutics annual meeting through a live transmission—the first ever—of a remote interventional procedure using the CorPath GRX system. More >

Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device
Source: Streetwise Reports  (9/5/18)
A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. More >

Medical Device Firm Anticipates Benefit from Patent Ruling
Source: Streetwise Reports  (8/15/18)
This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent. More >

Medical Device Firm's Clinical Programs Progress in Q2/18
Source: Streetwise Reports  (8/15/18)
A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence. More >

Interim Readout for Pharma Trial 'Delivers Home Run'
Source: Streetwise Reports  (7/31/18)
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. More >